Subsequent purchase

Marek · 2025-04-22T11:47:16.197306Z

Press the cost price a little :D Now only -21% at x91

Sebi@Seebi

4D

🤦

•

9

•

Marcel@Mcl1991

4D

@Seebi 💁‍♂️

•

1

•

Marek@Marek007

4D

@Seebi I praise you for that. I'm also in your grandma's bingo club.

•

4

•

Investor18@Investor18

3D

@Seebi

You can now be seen under every post about Novo Nordisk - and I have the feeling that many people now know that you are much more critical of the share than the market.

I would still be interested to know what exactly your reasoning is behind this. In my view, Novo is currently at a historically low valuation level and has achieved an impressive operating margin of 48.2% in 2024.

Of course, I also see the risks, especially with regard to the increasing competition from companies such as Eli Lilly, which are catching up or even ahead in GLP-1 preparations with innovative products. But Novo Nordisk will not stand idly by - the company has the financial and technological means to respond.

Hence my serious question: what exactly are you so critical of that you think the share still has significant downside potential?

•

10

•

Earnus@Earnus

3D

@Investor18 Unfortunately, this does not lead to much - I had already tried to elicit my own arguments from this expert. The result was an answer from ChatGPT.

Simply ignore him and don't offer him a platform. With his idiosyncratic humor, he just wants to hold up a mirror to Novo buyers. Provided you want to classify it as humor at all.

•

6

•

Olli@Olli68

3D

@Investor18 The market is proving @Seebi right. And the next quarterly figures and in particular the outlook will certainly show this.

•

3

•

Sebi@Seebi

3D

@Earnus You've already tried it? What? How many more arguments do you want? An answer from Chatgpt😄😄😄🤦 Please ignore me, block me, whatever, so I can be spared this. Otherwise I'll block you you troll

••

Sebi@Seebi

3D

@Investor18 I have now commented under almost every post on what I find so critical about this share and, as you can see, the market proves me right. To your question. Minus 50% annual balance sheet, Trump his tariffs, eternal studies that bring nothing positive, patents expire, clearly the competition. Quarterly figures and I could go on.

••

Earnus@Earnus

3D

@Seebi That's amazing. I would have expected more from you. But if you're constantly waiting for new posts on $NOVO B, you can get confused with your intellectual outpourings. That seems to be a general problem with you when you call other people "trolls".

It's actually a really reasonable community here - but unfortunately there always have to be negative outliers. So feel free to block me. Better suggestion: Delete your profile or try to be reasonable and make relevant posts.

•

5

•

Sebi@Seebi

3D

@Earnus something is wrong with you, have a nice life

••

Earnus@Earnus

3D

@Seebi It's a shame that when things get uncomfortable, people try to escape. Sad!

••

Ver todas las 10 respuestas adicionales

SemiGrowth@SemiGrowth

3D

a good buy. Diabetes is becoming a widespread disease and weight loss is on top of that

•

4

•

Silas W.@DynasticGrind

3D

What's going on in the comments? Are we all going to see each other in the Octagon soon or what? Such heated tempers in a stock market forum?! Ewww, ewww, ewww...

•

2

•

Legend@Zilong

1D

Sebastian just wanted some attention

••

Sebi@Seebi

1D

@Zilong Who is Sebastian?

••